In Nepal, pharmacists are legally permitted to dispense medication abortion drugs with a prescription but provision of mifepristone/misoprostol without a prescription is prohibited. However, one in five Nepalese women seeking medication abortion pills do so directly from pharmacies. This mixed-methods study aimed to understand pharmacy workers' knowledge of and practices related to medication abortion care and the reasons behind their provision or non-provision of these pills with and without a prescription. We surveyed 489 pharmacy workers and conducted semi-structured interviews with 25 pharmacy workers in major cities in Nepal's Koshi province. Our survey findings revealed that pharmacy workers are knowledgeable about the legal status of medication abortion (n = 414, 85%), medication abortion in general (n = 404, 83%), and its timing for use (n = 347, 86%). About 16% of pharmacy workers (n = 77) reported stocking and selling medication abortion pills, all in the form of combination packages of mifepristone/misoprostol; the average price was Nepali Rupees 660 (USD5). Pharmacy workers who stocked and sold medication abortion pills reported doing so because of the legal permissibility of the practice and community demand; most required a prescription prior to dispensing the medications. Those who did not stock mifepristone/misoprostol cited lack of training, confusion regarding the legal status of medication abortion, business risks associated with provision, and the inconsistent supply of the combination packages. The role of small, community-based pharmacies as service delivery points for medication abortion as a means to expanding access to safe, effective, and accessible care merits further consideration by researchers and policy makers in Nepal.
Rijal et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: